BeStock  
Stocks › ARWR

Arrowhead Pharmaceuticals ARWR

US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q4, ended Sep 2026

Revenue$37.79M-85.3% YoY
Operating profit-$436.63M-1,089.9% YoY
Net profit-$428.89M-2,760.4% YoY
Diluted EPS-$3.01-1,572.2% YoY
Free cash flow-$195.83M-1,606.2% YoY
Operating cash flow-$192.40M

Revenue, last 8 quarters

$2.5MDec '24$542.7MMar '25$27.8MJun '25$256.5MSep '25$264.0MDec '25$73.7MMar '26$75.3MJun '26$37.8MSep '26

Net profit, last 8 quarters

$-175.2MDec '24$367.9MMar '25$-178.7MJun '25$16.1MSep '25$28.2MDec '25$-137.6MMar '26$-178.9MJun '26$-428.9MSep '26

Diluted EPS by quarter

-1.39Dec '242.75Mar '25-1.26Jun '25-0.18Sep '250.22Dec '25-0.93Mar '26-1.36Jun '26-3.01Sep '26

Free cash flow by quarter

$-153.8MDec '24$454.8MMar '25$-157.1MJun '25$13.0MSep '25$11.3MDec '25$81.9MMar '26$-181.3MJun '26$-195.8MSep '26

Annual revenue

$138.3MFY21$243.2MFY22$240.7MFY23$3.6MFY24$829.4MFY25$450.8MFY26

Profitability & balance sheet

Gross margin99.6%
Operating margin-156.9%
Net margin-160.6%
Return on equity-280.5%
Return on assets-46.4%
Return on invested capital-73.2%
Current ratio4.14
Liabilities / assets97.1%
Cash & investments$1.19B
Total debt$994.70M
Net cash (debt)$198.29M

Income statement

Line item 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Total Revenue as Reported $450.82M $37.79M $75.25M $73.74M $264.03M
Total Operating Revenue $450.82M $37.79M $75.25M $73.74M $264.03M
Cost of Revenue $1.80M – – – –
Gross Profit $449.02M – – – –
Operating Expense $1.16B $472.62M $245.35M $215.00M $223.22M
Selling and Admin Expenses $200.14M $66.75M $46.63M $41.24M $45.52M
-General & Admin Expense $200.14M $66.75M $46.63M $41.24M $45.52M
Research & Development $954.14M $405.47M $198.22M $173.25M $177.20M
Depreciation & Amortization & Depletion $1.91M $408,000.00 $494,000.00 $500,000.00 $504,000.00
-Depreciation & Amortization $1.91M $408,000.00 $494,000.00 $500,000.00 $504,000.00
Operating Profit -$707.17M -$436.63M -$170.09M -$141.26M $40.81M
Net Non-Operating Interest Income (Expense) -$35.84M -$8.43M -$7.63M -$6.98M -$12.82M
Non-Operating Interest Income $57.86M $14.37M $16.94M $16.87M $9.69M
Non-Operating Interest Expense $93.71M $22.80M $24.56M $23.85M $22.51M
Other Income (Expense) $19.10M $9.34M -$1.19M $10.67M $277,000.00
Earnings from Equity Interest -$3.88M $5.31M -$2.47M -$6.72M –
Special Income (Charges) $19.00M $0.00 $0.00 $19.00M –
-Gain on Sale of Property/Plant/Equipment $19.00M $0.00 $0.00 $19.00M –
Other Non-Operating Income (Expenses) $3.98M $4.03M $1.29M -$1.61M $277,000.00
Pretax Profit -$723.92M -$435.71M -$178.91M -$137.57M $28.27M
Tax -$6.78M -$6.83M $11,000.00 $7,000.00 $29,000.00
Net Profit -$717.13M -$428.89M -$178.92M -$137.57M $28.24M
Profit from Continuing Operations -$717.13M -$428.89M -$178.92M -$137.57M $28.24M
Minority Interests $7.07M -$884,000.00 $15.36M -$4.84M -$2.57M
Net Income to Parent Company -$724.21M -$428.00M -$194.28M -$132.73M $30.81M
Net Income to Common Stockholders -$724.21M -$428.00M -$194.28M -$132.73M $30.81M
Basic EPS -$5.11 -$3.01 -$1.36 -$0.93 $0.22
Diluted EPS -$5.11 -$3.01 -$1.36 -$0.93 $0.22

Balance sheet

Line item 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Total Assets $1.74B $1.74B $2.11B $2.27B $1.60B
Total Current Assets $1.29B $1.29B $1.67B $1.84B $1.17B
Cash and Cash Equivalents & Short-Term Investments $1.19B $1.19B $1.60B $1.78B $916.61M
-Cash and Cash Equivalents $62.74M $62.74M $19.69M $147.53M $71.37M
-Short Term Investments $1.13B $1.13B $1.58B $1.64B $845.24M
Receivables $9.93M $9.93M $8.56M $15.69M $218.87M
-Accounts Receivable $9.93M $9.93M $8.56M $15.69M $218.87M
Prepaid Assets $31.58M $31.58M $25.37M $21.72M $16.05M
Inventory $9.08M $9.08M – – –
Other Current Assets $45.65M $45.65M $35.52M $18.25M $22.86M
Total Non-Current Assets $449.04M $449.04M $440.60M $428.51M $429.79M
Net PPE $429.65M $429.65M $428.97M $417.62M $421.95M
-Gross PPE $533.33M $533.33M $526.21M $508.90M $508.09M
-Accumulated Depreciation -$103.68M -$103.68M -$97.24M -$91.29M -$86.15M
Goodwill and Other Intangible Assets $5.16M $5.16M $5.59M $6.01M $6.44M
-Other Intangible Assets $5.16M $5.16M $5.59M $6.01M $6.44M
Other Non-Current Assets $14.23M $14.23M $6.05M $4.89M $1.41M
Total Liabilities $1.69B $1.69B $1.65B $1.67B $1.04B
Total Current Liabilities $311.34M $311.34M $283.35M $295.22M $347.43M
Payables $30.15M $30.15M $29.89M $32.86M $84.35M
-Accounts Payable $30.15M $30.15M $27.78M $30.75M $32.94M
-Total Tax Payable $0.00 $0.00 $0.00 $0.00 $10.89M
Current Accrued Expenses $137.04M $137.04M $107.52M $94.84M $92.94M
Short-Term Debt and Capital Lease Obligation $45.50M $45.50M $45.32M $47.77M $47.53M
-Current Debt $40.00M $40.00M $40.00M $40.00M $40.00M
-Current Capital Lease Obligation $5.50M $5.50M $5.32M $7.77M $7.53M
Current Deferred Liabilities $91.65M $91.65M $94.60M $108.54M $111.93M
Other Current Liabilities $7.01M $7.01M $6.02M $11.21M $10.68M
Total Non-Current Liabilities $1.38B $1.38B $1.36B $1.37B $694.06M
Long Term Debt and Capital Lease Obligation $954.70M $954.70M $938.37M $941.69M $265.24M
-Long Term Debt $838.88M $838.88M $824.07M $841.58M $163.11M
-Long Term Capital Lease Obligation $115.81M $115.81M $114.30M $100.11M $102.13M
Non-Current Deferred Liabilities $21.34M $21.34M $31.74M $48.62M $53.83M
Other Non-Current Liabilities $400.38M $400.38M $392.51M $383.83M $375.00M
Total Equity $50.50M $50.50M $466.04M $598.92M $562.70M
Stockholders' Equity $50.31M $50.31M $465.53M $613.98M $568.42M
Capital Stock $237,000.00 $237,000.00 $237,000.00 $236,000.00 $233,000.00
-Common Stock $237,000.00 $237,000.00 $237,000.00 $236,000.00 $233,000.00
Additional Paid-In Capital $2.46B $2.46B $2.44B $2.40B $2.21B
Retained Earnings -$2.35B -$2.35B -$1.92B -$1.73B -$1.60B
Less: Treasury Stock -$53.19M -$53.19M -$53.19M -$53.19M -$53.19M
Gains/Losses Not Affecting Retained Earnings -$7.65M -$7.65M -$1.23M $742,000.00 $6.70M
Minority Interests $191,000.00 $191,000.00 $512,000.00 -$15.06M -$5.73M
-Dividends Payable – – $2.11M $2.11M $40.52M

Cash flow

Line item 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Operating Cash Flow -$271.95M -$192.40M -$177.47M $84.44M $13.48M
Net cash flow from continuing operations -$271.95M -$192.40M -$177.47M $84.44M $13.48M
Net Income from Continuing Operations -$717.13M -$428.89M -$178.92M -$137.57M $28.24M
Gain/Loss from Continuing Operations -$14.72M -$4.87M $2.45M -$12.28M -$19,000.00
Depreciation & Depletion & Amortization $26.62M $7.21M $6.66M $6.37M $6.39M
Other Non-Cash Items $307.20M $237.13M $23.82M $23.74M $22.51M
Change in Working Capital $60.90M -$19.95M -$45.51M $188.15M -$61.79M
-Change in Receivables -$3.29M -$1.38M $6.95M $203.19M -$212.05M
-Change in Inventory -$9.08M – – – -$451,000.00
-Change in Prepaid Assets -$57.10M -$27.16M -$21.53M $4.77M -$13.18M
-Change in Payables and Accrued Expense $29.77M $35.00M $3.83M -$10.83M $1.76M
-Change in Other Current Liabilities -$4.54M -$982,000.00 -$1.13M -$1.21M -$1.21M
-Change In Other Working Capital $105.13M -$16.36M -$33.63M -$8.21M $163.34M
Net cash flow from investing -$670.48M $203.86M $43.68M -$894.28M -$23.74M
Net Cash Flow from Continuing Investing Activities -$670.48M $203.86M $43.68M -$894.28M -$23.74M
Net PPE Purchase and Sale -$12.00M -$3.43M -$3.85M -$2.57M -$2.15M
Net Investment Purchase and Sale -$443.49M $422.29M $47.54M -$891.72M -$21.59M
Net Other Investing Changes -$215.00M – – – –
Financing Cash Flow $776.82M -$3.70M -$449,000.00 $795.72M -$14.75M
Net Cash Flow from Continuing Financing Activities $776.82M -$3.70M -$449,000.00 $795.72M -$14.75M
Net Issuance Payments Of Debt $578.52M -$133.59M -$33.39M $812.17M -$66.68M
Net Common Stock Issuance $206.11M $130.00M $27.95M $1.32M $46.83M
Proceeds from Stock Option Exercised $114.73M $1.97M $2.62M $105.05M $5.10M
Net Other Financing Charges -$122.55M -$2.09M $2.37M – –
Ending Cash Balance $62.74M $62.74M $54.76M $188.52M $201.64M
Net Change in Cash -$165.61M $7.76M -$134.24M -$14.12M -$25.01M
Beginning Cash Balance $226.55M $54.76M $188.52M $201.64M $226.55M
Effect of Exchange Rate Changes $1.80M $220,000.00 $477,000.00 $997,000.00 $106,000.00
Free Cash Flow -$283.94M -$195.83M -$181.32M $81.88M $11.33M

Discussion

No comments yet — be the first to weigh in on ARWR.

Sign in to join the discussion.

Scroll to Top